I. Barr

Louise A. Carolan, L. Carolan, I. Barr, 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Investigating Viral Interference Between Influenza A Virus and Human Respiratory Syncytial Virus in a Ferret Model of Infection

Louise A. Carolan, L. Carolan, I. Barr, 2018, The Journal of infectious diseases.

TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses

Louise A. Carolan, L. Carolan, T. Guarnaccia, 2014, Journal of Virological Methods.

Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses

Louise A. Carolan, L. Carolan, T. Guarnaccia, 2015, Journal of Virology.

Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.

Keiji Fukuda, Richard Webby, Takato Odagiri, 2010, Vaccine.

The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006.

I. Barr, A. Hurt, N. Komadina, 2007, Antiviral research.

Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.

I. Barr, A. Hurt, N. Komadina, 2007, Antiviral research.

Seroprevalence of Seasonal and Pandemic Influenza A in Kuala Lumpur, Malaysia in 2008–2010

I. Barr, A. Hurt, I. Sam, 2013, Journal of medical virology.

SIAT-1 cells show improved isolation rates for recent human influenza 1 viruses compared to conventional MDCK cells 2 3 Running title : Isolating influenza virus in MDCK-SIAT 1 and MDCK cells

I. Barr, K. Laurie, J. Mosse, 2008 .

Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children.

I. Barr, L. Haaheim, A. Hampson, 2006, Vaccine.

Influenza Gain-of-Function Experiments: Their Role in Vaccine Virus Recommendation and Pandemic Preparedness

R. Webster, R. Webby, A. Kelso, 2014, mBio.

Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID‐19 pandemic

David W. Smith, I. Barr, J. Tang, 2021, Journal of medical virology.

A Tale of Two Mutations: Beginning to Understand the Problems with Egg-Based Influenza Vaccines?

I. Barr, K. Subbarao, 2019, Cell host & microbe.

Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial.

I. Barr, A. Wilder-Smith, M. Chen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Circulation and characterization of seasonal influenza viruses in Cambodia, 2012‐2015

I. Barr, A. Hurt, A. Parry, 2019, Influenza and other respiratory viruses.

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia‐Pacific region

I. Barr, L. Jennings, P. Buchy, 2018, Influenza and other respiratory viruses.

Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.

I. Barr, J. Mosse, A. Hurt, 2007, Antiviral research.

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

S. Madhi, H. Zar, A. Gebremedhin, 2022, The Lancet.

Large trials confirm immunogenicity of H1N1 vaccines

H. Kelly, I. Barr, 2010, The Lancet.

Six-monthly versus annual influenza vaccination in older adults: an observer-blinded, active- comparator controlled, randomised superiority trial

I. Barr, A. Wilder-Smith, M. Chen, 2019 .

Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.

I. Barr, P. Foster, D. Knight, 2015, American journal of respiratory and critical care medicine.

Targeting PI3K-p110a Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease

I. Barr, P. Foster, D. Knight, 2015 .

Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015

J. Wong, B. Cowling, S. Riley, 2018, PloS one.

Pandemic ( H 1 N 1 ) 2009 Risk for Frontline Health Care Workers

A. Kelso, I. Barr, A. Cheng, 2011 .

Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, Singapore

I. Barr, J. Tang, A. Wilder-Smith, 2010, Emerging infectious diseases.

Variation by lineage in serum antibody responses to influenza B virus infections

Yiu Chung Lau, J. Peiris, Peng Wu, 2020, PloS one.

Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia

I. Barr, A. Hurt, B. Olsen, 2006, Archives of Virology.

Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.

A. Kelso, I. Barr, A. Hurt, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

I. Barr, K. Laurie, S. Kent, 2016, EBioMedicine.

Continental synchronicity of human influenza virus epidemics despite climactic variation

E. Holmes, I. Barr, J. Geoghegan, 2018, PLoS pathogens.

Rapid diagnostic test kits for influenza

I. Barr, A. Hurt, 2006 .

A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population.

I. Barr, A. Hurt, A. Hampson, 2005, Communicable diseases intelligence quarterly report.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2019.

I. Barr, Heidi Peck, V. Leung, 2021, Communicable diseases intelligence.

Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation

I. Barr, A. Hurt, Jen-Ren Wang, 2020, Journal of Biomedical Science.

Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine

I. Barr, S. Rockman, S. Lowther, 2013, Journal of Virology.

Ferrets as Models for Influenza Virus Transmission Studies and Pandemic Risk Assessments

Huachen Zhu, H. Nishiura, I. Barr, 2018, Emerging infectious diseases.

Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.

I. Barr, A. Hurt, Yi-Mo Deng, 2018, Virology.

Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?

I. Barr, K. Laurie, S. Rockman, 2020, Vaccines.

Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA

I. Barr, S. Rockman, C. Ong, 2011, Influenza and other respiratory viruses.

In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses

I. Barr, A. Hurt, J. Holien, 2009, Antimicrobial Agents and Chemotherapy.

Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong

J. Peiris, B. Cowling, V. Fang, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In vivo localization of a bispecific antibody which targets human t lymphocytes to lyse human colon cancer cells

S. Miescher, I. Barr, A. Lanzavecchia, 1989, International journal of cancer.

Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies

I. Barr, H. Macdonald, F. Buchegger, 1987, International journal of cancer.

Characterization and expression of a novel Porphyromonas gingivalis outer membrane protein, Omp28.

I. Barr, N. Slakeski, C. Moore, 2002, Oral microbiology and immunology.

Respiratory Illness in a Piggery Associated with the First Identified Outbreak of Swine Influenza in Australia: Assessing the Risk to Human Health and Zoonotic Potential

I. Barr, M. O'Dea, P. Effler, 2019, Tropical medicine and infectious disease.

Divergent Human-Origin Influenza Viruses Detected in Australian Swine Populations

I. Barr, C. Baas, A. Hurt, 2018, Journal of Virology.

Neuraminidase-inhibiting antibody is a correlate of cross-protection 2 against lethal H 5 N 1 influenza in ferrets immunised with seasonal influenza 3 vaccine

I. Barr, S. Rockman, S. Lowther, 2013 .

Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus.

I. Barr, L. Brown, D. Jackson, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Characterization of two outer membrane protein antigens of Porphyromonas gingivalis that are protective in a murine lesion model.

I. Barr, E. Reynolds, B. Ross, 2004, Oral microbiology and immunology.

A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents

I. Barr, H. Marshall, L. Giles, 2022, Vaccines.

A comparison of rapid point-of-care tests for the detection of avian influenza A(H7N9) virus, 2013.

A. Kelso, I. Barr, C. Baas, 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

SARS-CoV-2 does not replicate in embryonated hen’s eggs or in MDCK cell lines

I. Barr, J. Druce, Cleve Rynehart, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Detection of influenza in managed quarantine in Australia and the estimated risk of importation

B. Cowling, I. Barr, K. Subbarao, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human seasonal in ﬂ uenza under COVID-19 and the potential consequences of in ﬂ uenza lineage elimination

I. Barr, S. Valkenburg, Cowling, 2021 .

Resurgence of avian influenza virus

I. Barr, M. Wille, 2022, Science.

Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay

I. Barr, L. Ng, E. Ren, 2006, BMC infectious diseases.

Routine flow cytometric diagnosis of lymphoproliferative disorders

I. Barr, B. Toh, 1983, Journal of Clinical Immunology.

IL‐17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus

Xia Li, I. Barr, K. Laurie, 2021, Respirology.

Australia's notifiable diseases status, 2005: annual report of the National Notifiable Diseases Surveillance System.

I. Barr, R. Owen, K. Hope, 2007, Communicable diseases intelligence quarterly report.

Outbreak of influenza amongst residential school students in Malaysia.

I. Barr, K. Chua, A. Hampson, 2006, The Medical journal of Malaysia.

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults.

I. Barr, A. Hampson, D. Pond, 2006, Vaccine.

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

S. Maurer-Stroh, I. Barr, J. Mosse, 2015, The Journal of antimicrobial chemotherapy.

Laboratory-based influenza surveillance in New Caledonia, 1999-2003.

I. Barr, A. Berlioz-Arthaud, 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?

I. Barr, A. Hurt, K. Subbarao, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

High proportion of influenza B characterises the 2008 influenza season in Victoria.

H. Kelly, I. Barr, K. Grant, 2009, Communicable diseases intelligence quarterly report.

Heterosubtypic T‐cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza

I. Barr, K. Laurie, M. Hellard, 2008, Influenza and other respiratory viruses.

Comparison of epidemical features of seasonal influenza across different climatic zones in Australia

I. Barr, Wenbiao Hu, H. Bambrick, 2018 .

Influenza C infections in Western Australia and Victoria from 2008 to 2014

David W. Smith, I. Barr, Yi-Mo Deng, 2016, Influenza and other respiratory viruses.

Assessing the potential pandemic risk of recent avian influenza viruses

I. Barr, 2017, European Respiratory Journal.

Strategies for Improving Responses to DNA Vaccines

I. Barr, A. Lew, J. Boyle, 1999, Molecular medicine.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021.

I. Barr, K. Subbarao, Ammar Aziz, 2020, Communicable diseases intelligence.

Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018.

I. Barr, Heidi Peck, A. Todd, 2020, Communicable diseases intelligence.

Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2014.

A. Kelso, I. Barr, S. Sullivan, 2015, Communicable diseases intelligence quarterly report.

Avian influenza. Why the concern

I. Barr, F. Wong, 2016 .

Avian in fl uenza . Why the concern ?

I. Barr, 2016 .

Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection

I. Barr, L. Brown, J. McAuley, 2017, Virology Journal.

LYMPHOMA IMMUNOTYPING BY PARAFFIN COMPARATIVE STUDY

C. A. Bourne, I. Barr, B. Toh, 2007 .

Lymphoma Immunotyping by Paraffin Immunoperoxidase and Cell Suspension Methods – A Comparative Study

C. A. Bourne, I. Barr, B. Toh, 1986, Pathology.

Overexpression, purification, and refolding of a Porphyromonas gingivalis cysteine protease from Escherichia coli.

I. Barr, M. Margetts, E. Webb, 2000, Protein expression and purification.

Rapid identification of the origin of the matrix protein gene in vaccine candidate reassortants using real-time PCR and fluorescence-based melting curve analysis

I. Barr, A. Hampson, N. Komadina, 2004 .

A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.

I. Barr, K. Laurie, G. Lynch, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model

I. Barr, A. Hurt, Edin J Mifsud, 2022, Communications Biology.

Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation

A. Kelso, I. Barr, A. Hurt, 2009, Journal of Virology.

Running Title: Zanamivir-Resistant Influenza Viruses

A. Kelso, I. Barr, A. Hurt, 2009 .

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016‐17

I. Barr, M. Zambon, J. Ellis, 2020, Influenza and other respiratory viruses.

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Eneida L. Hatcher, S. Lindstrom, I. Barr, 2021, Emerging infectious diseases.

Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity

G. Besra, I. Barr, P. Doherty, 2009, Proceedings of the National Academy of Sciences.

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

B. Cowling, I. Barr, S. Valkenburg, 2021, Nature Communications.

DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults

T. Yeo, I. Barr, M. Chen, 2022, npj Vaccines.

Annual report of the National Influenza Surveillance Scheme, 2006.

I. Barr, Kathleen O’Brien, 2007, Communicable diseases intelligence quarterly report.

Evaluation of Vaccines for H5N1 Inﬂuenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization (cid:1)

I. Barr, S. Rockman, S. Lowther, 2009 .

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.

I. Barr, A. Hurt, J. McKimm-Breschkin, 2004, Virus research.

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020

David W. Smith, N. Stocks, I. Barr, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza antiviral resistance in the Asia-Pacific region during 2011.

A. Kelso, I. Barr, S. Leang, 2013, Antiviral research.

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

C. Davis, Xiyan Xu, I. Barr, 2014, Vaccine.

MDCK-SIAT1 Cells Show Improved Isolation Rates for Recent Human Inﬂuenza Viruses Compared to Conventional MDCK Cells (cid:1) †

I. Barr, K. Laurie, J. Mosse, 2008 .

Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise

R. Webby, E. Lau, G. Neumann, 2022, bioRxiv.

Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines.

I. Barr, S. Rockman, S. Lowther, 2012, Vaccine.

The use of pyrosequencer-generated sequence-signatures to identify the influenza B-lineage and the subclade of the B/Yamataga-lineage viruses from currently circulating human influenza B viruses.

A. Kelso, I. Barr, C. Baas, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Progressive emergence of an oseltamivir‐resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient

A. Kelso, I. Barr, J. Butler, 2013, Influenza and other respiratory viruses.

Mutations I117V and I117M and Oseltamivir Sensitivity of Pandemic (H1N1) 2009 Viruses

S. Maurer-Stroh, I. Barr, S. Leang, 2012, Emerging infectious diseases.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Ron A M Fouchier, Colin A Russell, Takato Odagiri, 2008, Vaccine.

Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000.

I. Barr, A. Hurt, R. Shaw, 2006, Communicable diseases intelligence quarterly report.

Detection of Low Pathogenicity Influenza A(H7N3) Virus during Duck Mortality Event, Cambodia, 2017

I. Barr, Yi-Mo Deng, E. Karlsson, 2018, Emerging infectious diseases.

Host-targeted Nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.

I. Barr, A. Hurt, Edin J Mifsud, 2020, Antiviral research.

Human respiratory syncytial virus and influenza seasonality patterns—Early findings from the WHO global respiratory syncytial virus surveillance

I. Barr, C. Bancej, J. Ellis, 2020, Influenza and other respiratory viruses.

Double dose oseltamivir for severe influenza—does it help?

I. Barr, A. Hurt, 2013, BMJ.

Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.

I. Barr, A. Hurt, S. Lowther, 2010, Antiviral research.

Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study

G. Milne, J. Kelso, I. Barr, 2016, Influenza and other respiratory viruses.

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months

I. Barr, K. Subbarao, Heidi Peck, 2022, Influenza and other respiratory viruses.

No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus

I. Barr, A. Cheng, K. Buising, 2011, Human Immunology.

Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection.

I. Barr, P. Veith, N. Slakeski, 2006, Vaccine.

Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection

Louise A. Carolan, L. Carolan, I. Barr, 2017, Journal of Virology.

Development and comparison of molecular assays for the rapid detection of the pandemic influenza A (H1N1) 2009 virus

I. Barr, W. Lam, D. Hui, 2010, Journal of medical virology.

Pandemic (H1N1) 2009 Risk for Frontline Health Care Workers

A. Kelso, I. Barr, A. Cheng, 2011, Emerging infectious diseases.

Limited novel influenza A (H1N1) 09 infection in travelling high‐school tour group

A. Kelso, I. Barr, K. Laurie, 2010, Influenza and other respiratory viruses.

A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009

I. Barr, D. Magliano, N. Grills, 2010, Australian and New Zealand journal of public health.

ISCOMs: an adjuvant with multiple functions

I. Barr, A. Sjölander, Anders Sjölander, 1998, Journal of leukocyte biology.

Off-season RSV epidemics in Australia after easing of COVID-19 restrictions

David W. Smith, E. Holmes, I. Barr, 2021, Nature Communications.

The importance of influenza vaccination during the COVID‐19 pandemic

I. Barr, J. McCauley, S. Rockman, 2021, Influenza and Other Respiratory Viruses.

The evolution and genetic diversity of avian influenza A(H9N2) viruses in Cambodia, 2015 – 2016

I. Barr, A. Hurt, Yi-Mo Deng, 2019, PloS one.

The evolution and genetic diversity of avian influenza A(H9N2) viruses in Cambodia, 2015 #_#x2013; 2016

I. Barr, A. Hurt, Yi-Mo Deng, 2019 .

Diversity of A(H5N1) clade 2.3.2.1c avian influenza viruses with evidence of reassortment in Cambodia, 2014-2016

I. Barr, A. Hurt, P. Buchy, 2019, PloS one.

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).

N. Dziuba, I. Barr, A. Hurt, 2008, Virology.

Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19

Daryl R. Cheng, I. Barr, A. Daley, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intense interseasonal influenza outbreaks, Australia, 2018/19

S. Maurer-Stroh, I. Barr, Yi-Mo Deng, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic

I. Barr, M. Zambon, I. Sinha, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Laboratory diagnosis of human seasonal and pandemic influenza virus infection

Dominic E Dwyer, David W. Smith, I. Barr, 2006, The Medical journal of Australia.

Detection of Clade 2.3.4.4b Avian Influenza A(H5N8) Virus in Cambodia, 2021

I. Barr, Ammar Aziz, L. Izzard, 2023, Emerging infectious diseases.

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.

R. Webby, Dayan Wang, N. Cox, 2012, Vaccine.

A Novel Video Tracking Method to Evaluate the Effect of Influenza Infection and Antiviral Treatment on Ferret Activity

I. Barr, A. Hurt, D. Oh, 2015, PloS one.

Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.

David Smith, Philippe Buchy, Lesley Scott, 2009, Antiviral research.

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

I. Barr, A. Hurt, M. Parker, 2012, Drugs.

Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract

I. Barr, Edin J Mifsud, Miku Kuba, 2021, Viruses.

The contrasting phylodynamics of human influenza B viruses

Timothy B. Stockwell, Gavin J. D. Smith, T. Stockwell, 2015, eLife.

PHM 14: a novel monoclonal antibody that reacts with both normal and neoplastic human B cells but not B-CLL.

R. Atkins, I. Barr, W. Hancock, 2009, Scandinavian journal of haematology.

Critical Role of Constitutive Type I Interferon Response in Bronchial Epithelial Cell to Influenza Infection

I. Barr, S. Lowther, P. Wark, 2012, PloS one.

Characterization of a Novel Outer Membrane Hemin-Binding Protein of Porphyromonas gingivalis

I. Barr, N. Slakeski, S. Dashper, 2000, Journal of bacteriology.

Response of Porphyromonas gingivalis to Heme Limitation in Continuous Culture

I. Barr, C. Seers, P. Veith, 2008, Journal of bacteriology.

A novel and highly divergent Canine Distemper Virus lineage causing distemper in ferrets in Australia

I. Barr, A. Hurt, David T. Williams, 2021, bioRxiv.

Running title: Canine Distemper Virus in Ferrets

I. Barr, A. Hurt, David T. Williams, 2021 .

Locally Acquired Human Infection with Swine-Origin Influenza A(H3N2) Variant Virus, Australia, 2018

I. Barr, K. Subbarao, Yi-Mo Deng, 2020, Emerging infectious diseases.

Concurrent influenza and shigellosis outbreaks, Papua New Guinea, 2009.

A. Zwi, C. Macintyre, I. Barr, 2011, Emerging infectious diseases.

Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica

I. Barr, M. Aban, C. Baas, 2016, Journal of Virology.

Detection of Evolutionarily Distinct Avian Influenza A Viruses in Antarctica

S. Maurer-Stroh, A. Kelso, I. Barr, 2014, mBio.

Transmission of pandemic A/H1N1 2009 influenza on passenger aircraft: retrospective cohort study

A. Kelso, I. Barr, N. Wilson, 2010, BMJ : British Medical Journal.

Viruses in Antarctica Detection of Evolutionarily Distinct Avian Influenza A 2014

S. Maurer-Stroh, A. Kelso, I. Barr, 2014 .

Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution

D. Burke, I. Barr, A. Osterhaus, 2013, Science.

Comparative epidemiology, phylogenetics, and transmission patterns of severe influenza A/H3N2 in Australia from 2003 to 2017

A. Chughtai, C. Macintyre, I. Barr, 2020, Influenza and other respiratory viruses.

Rapid communications Detection of adamantane-sensitive influenza A ( H 3 N 2 ) viruses in Australia , 2017 : a cause for hope ?

I. Barr, A. Hurt, K. Subbarao, 2017 .

Epidemiological and Virological Characteristics of Influenza Viruses Circulating in Cambodia from 2009 to 2011

A. Kelso, I. Barr, A. Hurt, 2014, PloS one.

Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.

I. Barr, A. Hurt, Yi-Mo Deng, 2008, Antiviral research.

Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children.

I. Barr, A. Hurt, 2008, Communicable diseases intelligence quarterly report.

New Technologies for Influenza Vaccines

I. Barr, K. Laurie, A. Wheatley, 2020, Microorganisms.

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

David F. Boyd, S. Tangye, F. Luciani, 2019, Nature Immunology.

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.

Louise A. Carolan, J. McVernon, L. Carolan, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.

A. Kelso, I. Barr, A. Hurt, 2011, Antiviral research.

Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines

I. Barr, K. Laurie, C. Baas, 2021, npj Vaccines.

Global circulation patterns of seasonal influenza viruses vary with antigenic drift

Trevor Bedford, Colin A. Russell, Derek J. Smith, 2015, Nature.

Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia — a seroprevalence study

H. Kelly, I. Barr, K. Laurie, 2011, The Medical journal of Australia.

Genetic variations on 31 and 450 residues of influenza A nucleoprotein affect viral replication and translation

I. Barr, A. Hurt, Jen-Ren Wang, 2020, Journal of Biomedical Science.

Multiplex Reverse Transcription-PCR for Simultaneous Surveillance of Influenza A and B Viruses

Timothy B. Stockwell, Uma S. Kamaraj, T. Stockwell, 2017, Journal of Clinical Microbiology.

Rapid Detection and Subtyping of Human Influenza A Viruses and Reassortants by Pyrosequencing

I. Barr, Yi-Mo Deng, N. Caldwell, 2011, PloS one.

Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors

I. Barr, A. Hurt, Hui-Ting Ho, 2006, Expert review of anti-infective therapy.

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.

I. Barr, A. Hurt, A. Hampson, 2004, Antiviral research.

Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.

Park Young-Joon, Philippe Buchy, Amanda Balish, 2013, Western Pacific surveillance and response journal : WPSAR.

Antibody landscapes after influenza virus infection or vaccination

C. A. Russell, Judith M. Fonville, P. Horby, 2014, Science.

Avian influenza in the Greater Mekong Subregion, 2003-2018.

I. Barr, A. Hurt, Yi-Mo Deng, 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The Recent Establishment of North American H10 Lineage Influenza Viruses in Australian Wild Waterfowl and the Evolution of Australian Avian Influenza Viruses

Gavin J. D. Smith, I. Barr, A. Hurt, 2013, Journal of Virology.

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

I. Barr, D. Vijaykrishna, S. Sullivan, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model

Sebastian Maurer-Stroh, James M. McCaw, Jennifer Mosse, 2013, PLoS pathogens.

Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation

Xia Li, I. Barr, K. Laurie, 2022, Frontiers in Immunology.

Ibrutinib may impair serological responses to influenza vaccination

I. Barr, C. Tam, J. Trubiano, 2017, Haematologica.

Reliable universal RT-PCR assays for studying influenza polymerase subunit gene sequences from all 16 haemagglutinin subtypes.

Y. Guan, J. Peiris, L. Poon, 2007, Journal of virological methods.

A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses

I. Barr, Ammar Aziz, Yi-Mo Deng, 2022, bioRxiv.

Loop-Mediated Isothermal Amplification for Influenza A (H5N1) Virus

Y. Guan, L. Poon, Kwok-Hung Chan, 2007, Emerging infectious diseases.

A randomised trial of two 2-dose influenza vaccination strategies for patients following autologous haematopoietic stem cell transplantation.

I. Barr, K. Subbarao, S. Harrison, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore

A. Cook, W. Lim, A. Kelso, 2013, Influenza and other respiratory viruses.

Analgesic and adjuvant properties of exercise with vaccinations in healthy young population

I. Barr, E. Bohn-Goldbaum, R. Booy, 2021, Human vaccines & immunotherapeutics.

Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.

David W. Smith, S. Maurer-Stroh, A. Kelso, 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore.

S. Maurer-Stroh, I. Barr, Yi-Mo Deng, 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Thymic sensitivity to sex hormones develops post-natally; an in vivo and an in vitro study.

I. Barr, J. Funder, B. Toh, 1984, Journal of Immunology.

ISCOMs (immunostimulating complexes): The first decade

I. Barr, G. Mitchell, I. G. Barr, 1996, Immunology and cell biology.

Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010

W. Lim, I. Barr, M. Chen, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore

A. Cook, W. Lim, I. Barr, 2014, BMC Infectious Diseases.

Human influenza is more effective than avian influenza at antiviral suppression in airway cells.

I. Barr, P. Wark, P. Hansbro, 2011, American journal of respiratory cell and molecular biology.

A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses.

I. Barr, Yi-Mo Deng, L. Jelley, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Effectiveness of public health measures in mitigating pandemic influenza spread: a prospective sero-epidemiological cohort study.

P. Kelly, A. Cook, A. Kelso, 2010, The Journal of infectious diseases.

Rapid Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Single Base Pair RT-PCR and High-Resolution Melting

I. Barr, A. Hurt, S. Tong, 2011, PloS one.

Influenza-Specific Antibody-Dependent Phagocytosis

I. Barr, K. Laurie, S. Kent, 2016, PloS one.

WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.

R. Webby, Dayan Wang, N. Cox, 2014, Vaccine.

Performance of six influenza rapid tests in detecting human influenza in clinical specimens.

I. Barr, A. Hurt, Ian G Barr, 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Structural and functional characterisation of ferret interleukin-2

J. Newman, I. Barr, K. Laurie, 2015, Developmental & Comparative Immunology.

The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia.

I. Barr, K. Subbarao, Yi-Mo Deng, 2022, Communicable diseases intelligence.

Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.

Deborah Middleton, Louise A. Carolan, L. Carolan, 2010, The Journal of infectious diseases.

Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact

J. McVernon, A. Kelso, I. Barr, 2014, The Journal of antimicrobial chemotherapy.

Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience

I. Barr, S. Rockman, J. McCauley, 2022, Vaccines.

Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection

P. Horby, H. Wertheim, J. Farrar, 2015, The Journal of infection.

What serosurveillance studies tell us about the 2009 influenza pandemic

I. Barr, G. Dowse, 2011 .

Absence of cross‐reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months–9 years: a prospective study

J. McVernon, A. Kelso, I. Barr, 2010, Influenza and other respiratory viruses.

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines

I. Barr, K. Laurie, S. Rockman, 2023, Frontiers in Immunology.

Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion

I. Barr, S. Rockman, C. Ong, 2012, Influenza and other respiratory viruses.

Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

David W. Smith, Bin Wang, S. Maurer-Stroh, 2012, The Journal of infectious diseases.

The Coming Era of Quadrivalent Human Influenza Vaccines

I. Barr, L. Jelley, 2012, Drugs.

Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model

A. McLean, I. Barr, J. McCaw, 2010, Journal of Virology.

Loop-Mediated Isothermal Amplifi cation for Infl uenza A (H5N1) Virus

Y. Guan, Kwok-Hung Chan, Honglin Chen, 2007 .

Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors.

I. Barr, Ammar Aziz, M. Baz, 2022, Antiviral research.

Universal Influenza B Virus Genomic Amplification Facilitates Sequencing, Diagnostics, and Reverse Genetics

Timothy B. Stockwell, T. Stockwell, I. Barr, 2014, Journal of Clinical Microbiology.

Emergence of a novel influenza A(H7N9) virus

Norman J. MacDonald, Goossens, Antwerp, 2013 .

Performance of influenza rapid point‐of‐care tests in the detection of swine lineage A(H1N1) influenza viruses

Aeron C. Hurt, Ian G. Barr, A. Kelso, 2009, Influenza and other respiratory viruses.

Reassortants in recent human influenza A and B isolates from South East Asia and Oceania.

I. Barr, A. Hurt, R. Shaw, 2003, Virus research.

Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers.

I. Barr, J. Druce, C. Birch, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial.

J. Peiris, B. Cowling, D. Skowronski, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Burden of influenza B virus infection and considerations for clinical management.

I. Barr, A. Hurt, H. Zaraket, 2020, Antiviral research.

Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses

Louise A. Carolan, L. Carolan, I. Barr, 2022, Viruses.

Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

I. Barr, J. McCauley, R. Donis, 2018, npj Vaccines.

A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.

I. Barr, A. Hurt, A. Hampson, 2004, Virus research.

2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.

A. Cook, W. Lim, A. Kelso, 2010, JAMA.

Utilising animal models to evaluate oseltamivir efficacy against influenza A and B viruses with reduced in vitro susceptibility

S. Maurer-Stroh, I. Barr, A. Hurt, 2020, PLoS pathogens.

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.

I. Barr, J. Mosse, A. Hurt, 2004, Antiviral research.

Comparability of Different Methods for Estimating Influenza Infection Rates Over a Single Epidemic Wave

P. Kelly, A. Cook, W. Lim, 2011, American journal of epidemiology.

Research articleSeroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H 1 N 1 2009

P. Kelly, A. Kelso, I. Barr, 2016 .

Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009

P. Kelly, A. Kelso, I. Barr, 2010, BMC infectious diseases.

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant

N. Petrovsky, I. Barr, M. Aban, 2016, Vaccine.

Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020

I. Barr, Ammar Aziz, Yi-Mo Deng, 2021, Journal of virology.

Risk Factors for Pandemic (H1N1) 2009 Virus Seroconversion among Hospital Staff, Singapore

A. Cook, W. Lim, I. Barr, 2010, Emerging infectious diseases.

Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

I. Barr, R. Donis, J. Katz, 2018, npj Vaccines.

Influenza virus infection history shapes antibody responses to influenza vaccination

Louise A. Carolan, H. Wertheim, L. Carolan, 2022, Nature Medicine.

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses

S. Maurer-Stroh, A. Kelso, I. Barr, 2013, Influenza and other respiratory viruses.

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

David F. Boyd, S. Tangye, F. Luciani, 2019, Nature Immunology.

The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia

I. Barr, K. Subbarao, J. Moselen, 2023, medRxiv.

Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009

Kee Seng Chia, Alex R. Cook, A. Cook, 2011, Emerging infectious diseases.

Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence

E. Holmes, H. Kelly, I. Barr, 2015, PLoS pathogens.

Retargeting of cytolytic T lymphocytes by heteroaggregated (bispecific) antibodies.

I. Barr, H. Macdonald, F. Buchegger, 1988, Cancer Detection and Prevention.

Transmission of influenza A(H1N1) 2009 pandemic viruses in Australian swine

I. Barr, P. Daniels, Yi-Mo Deng, 2012, Influenza and other respiratory viruses.

Molecular Epidemiology of Influenza A(H1N1)pdm09 Virus among Humans and Swine, Sri Lanka

Y. Guan, C. Cheung, L. Poon, 2014, Emerging infectious diseases.

Is the UK prepared for seasonal influenza in 2022–23 and beyond?

I. Barr, C. A. Martin, I. Stephenson, 2022, The Lancet Infectious Diseases.

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.

W. Abhayaratna, J. McVernon, I. Barr, 2016, Vaccine.

Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study

A. Cook, I. Barr, M. Chen, 2010, PloS one.

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia

M. Postma, G. Milne, J. Kelso, 2018, Vaccine.

Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia

J. McVernon, A. Kelso, I. Barr, 2013, Influenza and other respiratory viruses.

Annual report of the National Influenza Surveillance Scheme, 2007.

I. Barr, R. Owen, Beverly Paterson, 2008, Communicable diseases intelligence quarterly report.

The impact of climate and antigenic evolution on seasonal influenza virus epidemics in Australia

Dylan H. Morris, I. Barr, A. Hurt, 2020, Nature Communications.

Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization

I. Barr, S. Rockman, S. Lowther, 2009, Journal of Virology.

The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA.

I. Barr, R. Shaw, C. Durrant, 2006, Vaccine.

Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.

I. Barr, K. Laurie, S. Kent, 2013, The Journal of infectious diseases.

Oseltamivir reduces clinical illness in households in Bangladesh.

H. Kelly, I. Barr, 2015, The Lancet. Infectious diseases.

Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets

I. Barr, A. Hurt, P. Reading, 2022, FEMS microbes.

Phytoplankton Calcification in a High-CO2 World

Toby Tyrrell, E. Virginia Armbrust, Eric Rehm, 2008, Science.

Comparison of the incidence of influenza in relation to climate factors during 2000–2007 in five countries

Tze Ping Loh, Dominic E Dwyer, I. Barr, 2010, Journal of medical virology.

Screening and development of monoclonal antibodies for identification of ferret T follicular helper cells

I. Barr, S. Kent, A. Wheatley, 2021, Scientific reports.

Rapid evolution of the PB1-F2 virulence protein expressed by human seasonal H3N2 influenza viruses reduces inflammatory responses to infection

I. Barr, L. Brown, J. McAuley, 2017, Virology Journal.

Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients

I. Barr, C. A. Martin, I. Stephenson, 2022, Journal of Infection.

Influenza antivirals and resistance: the next 10 years?

A. Kelso, I. Barr, J. Butler, 2012, Expert review of anti-infective therapy.

Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults.

I. Barr, S. Kent, A. Wheatley, 2017, Vaccine.

Mja Guidelines for Assessing Qualitative Research Quality in Qualitative Research Criteria for Authors and Assessors in the Submission and Assessment of Qualitative Research Articles for the Medical Journal of Australia

G. Andrews, I. Baguley, D. Bennett, 2022 .

The Medical Journal of Australia

G. Andrews, I. Baguley, D. Bennett, 1965 .

Emergence of a novel influenza A(H7N9) virus

A. Kelso, I. Barr, 2013 .

ISCOMs and other saponin based adjuvants.

I. Barr, A. Sjölander, Cox, 1998, Advanced drug delivery reviews.

Communicable Diseases Intelligence Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020–2021

I. Barr, K. Subbarao, Ammar Aziz, 2022 .

Communicable Diseases Intelligence

I. Barr, K. Subbarao, D. Durrheim, 2023 .

Rapid detection of new B/Victoria-lineage haemagglutinin variants of influenza B viruses by pyrosequencing.

Xiyan Xu, I. Barr, Yi-Mo Deng, 2019, Diagnostic microbiology and infectious disease.

Rapid Detection of Human Respiratory Syncytial Virus A and B by Duplex Real-Time RT-PCR.

I. Barr, Yi-Mo Deng, A. Daley, 2021, Journal of virological methods.

Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.

I. Barr, J. Mosse, C. Baas, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

A comparison of pyrosequencing and neuraminidase inhibition assays for the detection of oseltamivir-resistant pandemic influenza A(H1N1) 2009 viruses.

A. Kelso, I. Barr, A. Hurt, 2011, Antiviral research.

Antibody landscapes after influenza virus infection or vaccination

Judith M. Fonville, P. Horby, H. Wertheim, 2014, Science.

Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model.

Louise A. Carolan, A. Kelso, I. Barr, 2010, The Journal of infectious diseases.

Hospital capacity and management preparedness for pandemic influenza in Victoria

I. Barr, P. Robinson, Ben Dewar, 2014, Australian and New Zealand journal of public health.

Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts

I. Barr, A. Wheatley, S. Rockman, 2023, bioRxiv.

The Recent Establishment of North American H10 Lineage Influenza Viruses in Australian Wild Waterfowl and the Evolution of Australian Avian Influenza Viruses

I. Barr, A. Hurt, Yi-Mo Deng, 2013, Journal of Virology.

Emergence of Influenza A(H7N4) Virus, Cambodia

I. Barr, Yi-Mo Deng, E. Karlsson, 2019, Emerging infectious diseases.

clinical and microbiological cure of M. conceptionense pneumonitis by using azithromycin and doxycycline in a patient with HIV/AIDS in the United States. About the Author Emergence of Influenza A(H7N4) Virus, Cambodia

I. Barr, Yi-Mo Deng, E. Karlsson, 2022 .

Evaluation of vaccines for H 5 N 1 influenza virus in ferrets reveals the potential for 2 protective single-shot immunisation

I. Barr, S. Rockman, S. Lowther, 2009 .

2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore.

A. Cook, A. Kelso, I. Barr, 2010, JAMA.

Phytoplankton Calcification in a High-CO2 World

A. Lapedes, M. Shaw, R. Garten, 2008, Science.

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.

W. Abhayaratna, J. McVernon, I. Barr, 2016, Vaccine.

American Journal of Epidemiology Practice of Epidemiology Comparability of Different Methods for Estimating Influenza Infection Rates over a Single Epidemic Wave

I. Barr, M. Chen, V. Lee, 2022 .

Comparison of epidemical features of seasonal influenza across different climatic zones in Australia

I. Barr, H. Bambrick, G. Milinovich, 2020 .

Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

S. Madhi, H. Zar, A. Gebremedhin, 2022, The Lancet.

Annual report of the National Influenza Surveillance Scheme, 2008.

I. Barr, R. Owen, Marlena C Kaczmarek, 2010, Communicable diseases intelligence quarterly report.

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza

I. Barr, S. Kent, J. Neaton, 2023, JCI insight.

Characteristics of a Widespread Community Cluster of H 275 Y Oseltamivir-Resistant A ( H 1 N 1 ) pdm 09 In fl uenza in Australia

S. Maurer-Stroh, A. Kelso, I. Barr, 2012 .